Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Drug-resistant TB news

Show

From To
MDR-TB treatment: Six drugs better than five

A regimen containing six drugs was more likely to cure multi-drug resistant tuberculosis (MDR-TB) than a regimen containing five drugs, a nine-country observational study has

Published
13 January 2016
By
Keith Alcorn
USAID announces new partnerships to combat MDR-TB

At last week’s launch of the National Action Plan for Combating Multidrug-Resistant Tuberculosis, the U.S. Agency for International Development announced expanded partnerships with Janssen, the maker of bedaquiline, the first tuberculosis drug to be produced since the 1950s, and Cepheid, maker of the GeneXpert rapid diagnostic test for drug-resistant tuberculosis.

Published
13 January 2016
From
Science Speaks
TAG’s Response to the U.S. Action Plan for Combating Multidrug Resistant Tuberculosis

Treatment Action Group (TAG) welcomes the release of the Obama Administration’s National Action Plan for Combating Multidrug-Resistant Tuberculosis. Strengthening the domestic and global and research efforts to address multidrug-resistant tuberculosis (MDR-TB) are critical to ending the suffering this preventable, curable disease needlessly causes. However, the targets set forth in this plan are not ambitious enough to effectively stop the spread of MDR-TB.

Published
11 January 2016
From
Treatment Action Group
Xpert MTB/RIF testing has reduced MDR-TB treatment delays in South Africa

Although the introduction of the Xpert MTB/RIF test for TB and drug-resistant TB has improved the time from clinic presentation to second-line treatment in South Africa since

Published
07 January 2016
By
Lesley Odendal
One in eight children with confirmed TB have drug-resistant TB in Cape Town

One in eight children with confirmed TB have drug-resistant TB in Cape Town, South Africa, according to a surveillance study of childhood TB drug-resistance, presented by Professor

Published
05 January 2016
By
Lesley Odendal
Death during MDR-TB treatment more likely in people with HIV and underweight or most drug-resistant patients

People living with HIV, those who are underweight and those with more extensive drug resistance are more likely to die during treatment for multi-drug resistant tuberculosis (MDR-TB),

Published
10 December 2015
By
Keith Alcorn
9-month MDR-TB regimen cures 82% in African study

A 9-month standardised treatment regimen for multi-drug resistant tuberculosis (MDR-TB) cured 82% of people recruited to an observational study in Francophone Africa, the 46th Union World Conference

Published
07 December 2015
By
Keith Alcorn
First new TB drugs in half a century reach just 2% of people who need them

MSF calls for companies to make new drugs to treat drug-resistant TB available and affordable.

Published
04 December 2015
From
MSF
New cohort study shows promise of dramatically shorter treatment option for multidrug - resistant TB

New findings from clinical studies presented at the 46th Union World Conference on Lung Health show promise for a shorter, 9 -month treatment course for MDR-TB. The standard treatment length recommended by the World Health Organization requires 24 months of treatment.

Published
03 December 2015
From
46th Union World Conference on Lung Health
New survey shows outdated TB policies and practices risking further spread of drug-resistant TB

Urgent phase-out needed for outdated policies of mandatory hospitalisation, re-treatment regimens that contribute to drug resistance, and sub-optimal diagnosis.

Published
03 December 2015
From
MSF
← First12345...21Next →

Filter by country